PRO.MED.CS Praha a. s.
We are an international pharmaceutical Rx company with family ownership and leadership, based in Prague, Czechia. We are a fully integrated company, with a strong focus on gastrointestinal and liver diseases, where unmet needs remain significant. PRO.MED.CS exports its products to more than 35 countries, with recent establishment in Latin America. Our mission is to help patients and doctors by bringing good medicine and making it better in areas of unmet needs. Our strategic vision is to be the partner of choice for Health Care Professionals in the management of gastrointestinal and liver diseases.
About us
Dr. Bares Award Ceremony 2026: Awards for Outstanding Achievements in Science and Medicine
On 4 June 2026, the Ceremony of the 17th annual Dr. Bares Award took place in Tbilisi, Georgia during the International Symposium of Gastroenterology, where we celebrated the achievements of this year's award winners.
Read more
PRO.MED.CS is announcing the Winners of the 17th annual Dr. Bares Award
On March 7, 2026, the International Committee of the Dr. Bares Award (DBA) held its final session, carefully reviewed all submissions and carried out a detailed evaluation and voting process.
Read more
Quality, affordable
medicinal products
We are a fully integrated pharmaceutical company. We develop our own pharmaceutical dosage forms, produce medicinal products that comply with strict European standards, and take care of everything in-house – from pre-formulations, stability studies and worldwide marketing authorisations right down to the package designs. We ensure that the entire supply chain runs seamlessly so that our medicinal products always get to where they’re needed.
About us
Human healthcare
Our goal is to care for and protect people’s health. This is why we focus all of our efforts on developing and producing high-quality medicinal products. We are continuously searching for new solutions that will help improve health outcomes and quality of life around the world.
With longstanding investments into research and innovation, we support research teams and independent laboratories in the search for new active substances and treatments.
Partnership & Research
Broad portfolio
of pharmaceutical products
The products in our broad portfolio primarily help in treating gastrointestinal tract diseases, but we also place significant focus on diseases of the cardiovascular and central nervous systems. Our current annual production volume exceeds one billion tablets, coated tablets and capsules. All of our products comply with strict pharmaceutical manufacturing standards in more than thirty countries worldwide where we operate.
See portfolioLatest news
Dr. Bares Award Ceremony 2026: Awards for Outstanding Achievements in Science and Medicine
On 4 June 2026, the Ceremony of the 17th annual Dr. Bares Award took place in Tbilisi, Georgia during the International Symposium of Gastroenterology, where we celebrated the achievements of this year's award winners.
PRO.MED.CS is announcing the Winners of the 17th annual Dr. Bares Award
On March 7, 2026, the International Committee of the Dr. Bares Award (DBA) held its final session, carefully reviewed all submissions and carried out a detailed evaluation and voting process.
The 17th edition of the Dr. Bares Award professional competition is entering its final stage
The Dr. Bares Award is one of the mostprestigious international awards in the field of gastroenterology and hepatology, supporting top-level scientific research and clinical practice. Of the 70 professional papers submitted from 11 countries, 33 have advanced to the international round. The winners, who will share a total financial prize of EUR 29,000, will be selected by a six-member panel of experts in early March 2026.
Careers
We are continually expanding our team and hiring professionals in a variety of fields. Perhaps you’re just the one we’re looking for!
Work for us